30.12.2014 Views

A-Textbook-of-Clinical-Pharmacology-and-Therapeutics-5th-edition

A-Textbook-of-Clinical-Pharmacology-and-Therapeutics-5th-edition

A-Textbook-of-Clinical-Pharmacology-and-Therapeutics-5th-edition

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

278 NEPHROLOGICAL AND RELATED ASPECTS<br />

absorbed through the nasal mucosa for it to be administered<br />

intranasally. It is selective for V 2 -receptors <strong>and</strong> lacks the pressor<br />

effect <strong>of</strong> ADH.<br />

Desmopressin is also used for nocturnal enuresis in<br />

children over seven years old, <strong>and</strong> intravenously in patients<br />

with von Willebr<strong>and</strong>’s disease before undergoing elective<br />

surgery, because it increases circulating von Willebr<strong>and</strong> factor.<br />

It also increases factor VIII in patients with mild/moderate<br />

haemophilia.<br />

Key points<br />

Volume depletion<br />

• Volume depletion can be caused by loss <strong>of</strong> blood or<br />

other body fluids (e.g. vomiting, diarrhoea, surgical<br />

fistulas).<br />

• Replacement should be with appropriate volumes <strong>of</strong><br />

crystalloid or blood in the case <strong>of</strong> haemorrhage.<br />

• Excessive renal loss <strong>of</strong> salt (e.g. Addison’s disease) or<br />

water (e.g. diabetes insipidus) can be due to renal or<br />

endocrine disorders <strong>and</strong> requires appropriate<br />

treatment (e.g. fludrocortisone in Addison’s disease,<br />

desmopressin in central diabetes insipidus).<br />

DISORDERED POTASSIUM ION BALANCE<br />

HYPOKALAEMIA<br />

Hypokalaemia commonly accompanies loss <strong>of</strong> fluid from the<br />

gastro-intestinal tract (e.g. vomiting or diarrhoea), or loss <strong>of</strong><br />

potassium ions into the urine due to diuretic therapy (see<br />

above). Hypokalaemia in untreated patients with hypertension<br />

is suggestive <strong>of</strong> mineralocorticoid excess (e.g. Conn’s syndrome,<br />

liquorice abuse). Bartter’s syndrome is a rare cause <strong>of</strong><br />

severe hypokalaemia that should be considered in normotensive<br />

children who are not vomiting. Severe hypokalaemia<br />

causes symptoms <strong>of</strong> fatigue <strong>and</strong> nocturia (because <strong>of</strong> loss <strong>of</strong><br />

renal concentrating ability), <strong>and</strong> can cause dysrhythmias. Mild<br />

degrees <strong>of</strong> hypokalaemia (<strong>of</strong>ten associated with diuretic use)<br />

are generally well tolerated <strong>and</strong> <strong>of</strong> little clinical importance.<br />

Risk factors for more serious hypokalaemia include:<br />

1. high-dose diuretics, especially combinations <strong>of</strong> loop<br />

diuretic <strong>and</strong> thiazide;<br />

2. other drugs that cause potassium loss/redistribution<br />

(e.g. systemic steroids, chronic laxative treatment, high<br />

dose β 2 -agonists);<br />

3. low potassium intake;<br />

4. primary or secondary hyperaldosteronism.<br />

POTASSIUM REPLACEMENT<br />

There are two ways to increase plasma potassium concentrations:<br />

potassium supplements, or potassium-sparing diuretics.<br />

POTASSIUM SUPPLEMENTS<br />

Potassium salts may be given orally as either an effervescent or<br />

slow-release preparation. Diet can be supplemented by foods<br />

with a high potassium content, such as fruit <strong>and</strong> vegetables<br />

(bananas <strong>and</strong> tomatoes are rich in potassium ions). Intravenous<br />

potassium salts are usually given as potassium chloride. This is<br />

used either to maintain body potassium levels in patients<br />

receiving intravenous feeding, or to restore potassium levels in<br />

severely depleted patients (e.g. those with diabetic ketoacidosis).<br />

The main danger associated with intravenous potassium<br />

is hyperkalaemia, which can cause cardiac arrest. Potassium<br />

chloride has the dubious distinction <strong>of</strong> causing the highest frequency<br />

<strong>of</strong> fatal adverse reactions. Potassium chloride solution<br />

is infused at a maximum rate <strong>of</strong> 10 mmol/hour unless there is<br />

severe depletion, when 20 mmol/hour can be given with electrocardiographic<br />

monitoring. Particular care is needed if there<br />

is impaired renal function. Potassium chloride for intravenous<br />

replacement should be dilute whenever possible (e.g. mini-bags<br />

<strong>of</strong> prediluted fluid); strong potassium solutions (the most dangerous)<br />

should be restricted to areas such as intensive care units<br />

where patients may need i.v. potassium while also severely<br />

restricting fluid intake.<br />

POTASSIUM-SPARING DIURETICS<br />

An alternative to potassium supplementation is to combine a<br />

thiazide or loop diuretic with a potassium-retaining diuretic<br />

(see above). Potassium-retaining diuretics are better tolerated<br />

than oral potassium supplements.<br />

Key points<br />

Disordered K metabolism<br />

• Hypokalaemia is caused by urinary or gastro-intestinal<br />

K loss in excess <strong>of</strong> dietary intake, or by a shift <strong>of</strong> K <br />

into cells. Diuretics are <strong>of</strong>ten the cause. Endocrine<br />

causes include Conn’s syndrome. β 2 -Agonists shift K <br />

into cells.<br />

• Mild hypokalaemia is <strong>of</strong>ten unimportant, but severe<br />

hypokalaemia can cause dysrhythmias. Hypokalaemia<br />

increases digoxin toxicity.<br />

• Emergency treatment (e.g. in diabetic ketoacidosis)<br />

involves intravenous replacement, which requires close<br />

monitoring (including ECG).<br />

• Foods rich in K include fruit <strong>and</strong> vegetables. Oral K <br />

preparations are unpalatable <strong>and</strong> not very effective.<br />

• K -retaining diuretics are used to prevent<br />

hypokalaemia. They predispose to hyperkalaemia,<br />

especially in patients with impaired renal function or<br />

with concomitant use <strong>of</strong> K supplements, ACEI or<br />

NSAIDs.<br />

HYPERKALAEMIA<br />

Hyperkalaemia in untreated patients suggests the possibility<br />

<strong>of</strong> renal failure or <strong>of</strong> mineralocorticoid deficiency (e.g. Addison’s<br />

disease). Most commonly, however, it is caused by drugs.<br />

Hyperkalaemia can develop either with potassium supplements

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!